Daily News Analysis » January 2024 » New Antibiotics: Zosurabalpin 5 Jan, 2023

New Antibiotics: Zosurabalpin 5 Jan, 2023

New antibiotic has been identified to target a drug-resistant bacterium.

New Antibiotics 

Why in news?

  • New antibiotic has been identified to target a drug-resistant bacterium. 

 

Key Points: 

  • New Class of Antibiotics: Researchers have discovered a new type of antibiotics that could potentially combat a drug-resistant bacterium called Acinetobacter baumannii.
  • Zosurabalpin: A specific antibiotic called zosurabalpin was found to be effective against carbapenem-resistant Acinetobacter baumannii (CRAB) strains, which are known to cause pneumonia and sepsis.
  • Mouse Model Testing: The effectiveness of zosurabalpin was tested in mouse models, where it successfully treated CRAB-induced pneumonia and sepsis.
  • Antibiotic Resistance: Acinetobacter baumannii strains that are resistant to antibiotics are challenging to treat in medical settings.
  • Tethered Macrocyclic Peptide (MCP): It is a specific type of compound that selectively kills Acinetobacter baumannii.